Prospective, single arm clinical study of low-dose relapsing radiotherapy combined with PD-1 in the treatment of recurrent lung cancer

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049367

Enrollment

Unknown

Registered

2021-08-01

Start date

2021-08-01

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Single arm group:None

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients with recurrent lung cancer; 2.There are measurable lesions in the lung, large lesions and small lesions at the same time; 3.ECOG score was 0-2; 4.Age >=18 years old.

Exclusion criteria

Exclusion criteria: 1.There was no previous radiotherapy for lung tumor lesions; 2.Estimated survival < 3 months.

Design outcomes

Secondary

Measure	Time frame
Objective Response Rate;Overall Survival;Progression Free Survival;	—

Primary

Measure	Time frame
Safety;Tolerance;	—

Countries

China

Contacts

Public ContactLi Guomiao

The Second People's Hospital of Neijiang

115398656@qq.com+86 15681413850

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026